nvidia boltz 2

The nvidia boltz 2 tag follows enterprise use of NVIDIA’s Boltz-2 NIM in pharmaceutical research. Current coverage focuses on Astellas Pharma’s deployment for membrane-protein drug discovery, using Tokyo-1 as a computational foundation and presenting results through a browser-based workflow familiar to chemists. The reported evaluation selected 10 compounds, all of which showed the expected medicinal effects, while the company said evaluated compounds fell by more than 90% and research time by more than 70%. This page collects reporting on how nvidia boltz 2 supports production-oriented scientific AI adoption, connecting advanced models with practical research infrastructure and day-to-day drug discovery work.